List of Excipients in API follitropin
✉ Email this page to a colleague
Detailed excipient profiles for follitropin
Excipient focus: BENZYL ALCOHOL
follitropin drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
follitropin drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
follitropin drug variants containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
follitropin drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| EMD Serono Inc | follitropin | 44087-1115 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
follitropin drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
follitropin drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
follitropin drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
follitropin drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
follitropin drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
follitropin drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| EMD Serono Inc | follitropin | 44087-1115 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
follitropin drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
follitropin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | follitropin | 0052-0313 |
| Organon LLC | follitropin | 78206-129 |
| >Company | >Ingredient | >NDC |
follitropin drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| EMD Serono Inc | follitropin | 44087-1115 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch